|
Status |
Public on Oct 20, 2016 |
Title |
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity
|
|
|
Overall design |
day 30 hiPSC-CMs from TKI project control lines treated with/without 1uM Sorafenib (TKI) for 72 hours
|
|
|
Contributor(s) |
Sharma A, Churko J |
Citation(s) |
28202772 |
|
Submission date |
Oct 19, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Jared Churko |
E-mail(s) |
jchurko@stanford.edu
|
Organization name |
Stanford
|
Department |
Radiology
|
Street address |
265 Campus Dr G1105 SIM1
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (10)
|
|
This SubSeries is part of SuperSeries: |
GSE89411 |
Tyrosine Kinase Inhibitor Cardiotoxicity |
|
Relations |
BioProject |
PRJNA349162 |
SRA |
SRP091772 |